Carnegie Capital Asset Management, LLC Astrazeneca PLC Transaction History
Carnegie Capital Asset Management, LLC
- $5.06 Billion
- Q3 2025
A detailed history of Carnegie Capital Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Carnegie Capital Asset Management, LLC holds 13,935 shares of AZN stock, worth $1.25 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,935
Previous 13,935
-0.0%
Holding current value
$1.25 Million
Previous $973,000
9.87%
% of portfolio
0.02%
Previous 0.02%
Shares
21 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...